共同药业
(300966)
| 流通市值：16.87亿 | | | 总市值：25.36亿 |
| 流通股本：7666.66万 | | | 总股本：1.15亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 133,827,483.67 | 157,140,791.92 | 141,181,205.23 | 130,486,537.6 |
| 结算备付金 | 0 | - | 0 | - |
| 拆出资金 | 0 | - | 0 | - |
| 交易性金融资产 | 1,010.7 | 1,010.63 | 1,010.63 | 1,010.5 |
| 衍生金融资产 | 0 | - | 0 | - |
| 应收票据及应收账款 | 257,875,528.31 | 234,723,715.07 | 204,637,654.13 | 202,188,554.48 |
| 其中：应收票据 | 18,481,550.85 | 22,515,024.53 | 15,969,258.05 | 21,645,710.62 |
| 应收账款 | 239,393,977.46 | 212,208,690.54 | 188,668,396.08 | 180,542,843.86 |
| 应收款项融资 | 4,827,537.43 | 6,061,995.64 | 9,623,992.21 | 7,829,570.58 |
| 预付款项 | 4,653,629.39 | 17,908,414.1 | 10,721,612.3 | 21,848,248.57 |
| 应收保费 | 0 | - | 0 | - |
| 应收分保账款 | 0 | - | 0 | - |
| 应收分保合同准备金 | 0 | - | 0 | - |
| 其他应收款合计 | 2,427,007.97 | 3,674,702.79 | 2,052,867.78 | 2,849,325.93 |
| 其中:应收利息 | 0 | - | 0 | - |
| 应收股利 | 0 | - | 0 | - |
| 买入返售金融资产 | 0 | - | 0 | - |
| 存货 | 440,055,287.92 | 433,172,804.78 | 384,797,242.09 | 383,824,667.7 |
| 合同资产 | 0 | - | 0 | - |
| 一年内到期的非流动资产 | 0 | - | 0 | - |
| 其他流动资产 | 10,913,227.35 | 19,741,864.32 | 16,981,792.75 | 9,294,465.23 |
| 流动资产合计 | 854,580,712.74 | 872,425,299.25 | 769,997,377.12 | 758,322,380.59 |
| 非流动资产: | | | | |
| 发放委托贷款及垫款 | 0 | - | 0 | - |
| 债权投资 | 0 | - | 0 | - |
| 其他债权投资 | 0 | - | 0 | - |
| 长期应收款 | 0 | - | 0 | - |
| 长期股权投资 | 48,332,445.18 | 48,320,488.02 | 48,268,996.23 | 48,553,666.14 |
| 其他权益工具投资 | 0 | - | 0 | - |
| 其他非流动金融资产 | 0 | - | 0 | - |
| 投资性房地产 | 17,699,533.22 | 17,857,043.03 | 18,014,552.84 | 18,172,062.65 |
| 固定资产 | 1,136,696,153.48 | 1,130,257,222.26 | 1,154,486,627.36 | 858,214,432.4 |
| 在建工程 | 761,804,636.83 | 730,989,301.94 | 694,413,010.74 | 856,414,467.39 |
| 生产性生物资产 | 0 | - | 0 | - |
| 油气资产 | 0 | - | 0 | - |
| 使用权资产 | 42,525.94 | 56,701.27 | 70,876.6 | 85,051.93 |
| 无形资产 | 49,323,853.4 | 49,602,459.68 | 49,881,065.96 | 50,159,672.24 |
| 开发支出 | 0 | - | 0 | - |
| 商誉 | 0 | - | 0 | - |
| 长期待摊费用 | 7,970,503.32 | 8,804,934.48 | 9,618,102.36 | 10,211,801.22 |
| 递延所得税资产 | 46,903,061.78 | 40,913,423.56 | 37,290,872.15 | 33,834,680.94 |
| 其他非流动资产 | 11,821,104.14 | 14,325,689.35 | 7,838,847.5 | 63,284,979.52 |
| 非流动资产合计 | 2,080,593,817.29 | 2,041,127,263.59 | 2,019,882,951.74 | 1,938,930,814.43 |
| 资产总计 | 2,935,174,530.03 | 2,913,552,562.84 | 2,789,880,328.86 | 2,697,253,195.02 |
| 流动负债: | | | | |
| 短期借款 | 222,153,151.38 | 291,238,917.77 | 294,303,069.17 | 252,273,011.1 |
| 向中央银行借款 | 0 | - | 0 | - |
| 吸收存款及同业存放 | 0 | - | 0 | - |
| 拆入资金 | 0 | - | 0 | - |
| 交易性金融负债 | 0 | - | 0 | - |
| 衍生金融负债 | 0 | - | 0 | - |
| 应付票据及应付账款 | 524,545,403.54 | 465,690,482.39 | 459,913,423.7 | 477,989,551.83 |
| 其中：应付票据 | 77,066,120 | 57,464,804.4 | 37,117,956 | 71,474,971.04 |
| 应付账款 | 447,479,283.54 | 408,225,677.99 | 422,795,467.7 | 406,514,580.79 |
| 预收款项 | 329,845.26 | 472,660.55 | 47,266.05 | 212,697.27 |
| 合同负债 | 605,760.17 | 2,104,842.75 | 1,226,484.65 | 1,192,191.8 |
| 卖出回购金融资产款 | 0 | - | 0 | - |
| 应付手续费及佣金 | 0 | - | 0 | - |
| 应付职工薪酬 | 5,551,980.57 | 6,368,448.76 | 9,514,285.4 | 5,253,938.75 |
| 应交税费 | 354,686.32 | 401,178.93 | 2,844,802.3 | 2,838,439.77 |
| 其他应付款合计 | 988,271.02 | 837,504.88 | 899,641.66 | 796,833.2 |
| 其中:应付利息 | 0 | - | 0 | - |
| 应付股利 | 0 | - | 0 | - |
| 应付分保账款 | 0 | - | 0 | - |
| 保险合同准备金 | 0 | - | 0 | - |
| 代理买卖证券款 | 0 | - | 0 | - |
| 代理承销证券款 | 0 | - | 0 | - |
| 一年内到期的非流动负债 | 39,152,910.81 | 28,454,955.23 | 24,609,710.86 | 21,444,124.39 |
| 其他流动负债 | 28,062,560.21 | 31,756,083.39 | 14,328,360.44 | 20,000,302.01 |
| 流动负债合计 | 821,744,569.28 | 827,325,074.65 | 807,687,044.23 | 782,001,090.12 |
| 非流动负债: | | | | |
| 长期借款 | 625,098,254.73 | 586,151,083.35 | 484,919,646.66 | 420,963,408.74 |
| 应付债券 | 340,325,879.53 | 333,989,211.11 | 327,722,176.41 | 321,446,330.06 |
| 优先股 | 0 | - | 0 | - |
| 永续债 | 0 | - | 0 | - |
| 租赁负债 | 0 | - | 0 | 0 |
| 长期应付款 | 0 | - | 0 | - |
| 长期应付职工薪酬 | 0 | - | 0 | - |
| 预计负债 | 4,333,250.51 | 4,648,020.47 | 4,648,020.47 | 0 |
| 递延收益 | 146,177,677.55 | 149,362,080.36 | 150,250,753.02 | 141,389,053.67 |
| 递延所得税负债 | 173,506.38 | 12,760.97 | 10,633.08 | 12,759.36 |
| 其他非流动负债 | 0 | - | 0 | - |
| 非流动负债合计 | 1,116,108,568.7 | 1,074,163,156.26 | 967,551,229.64 | 883,811,551.83 |
| 负债合计 | 1,937,853,137.98 | 1,901,488,230.91 | 1,775,238,273.87 | 1,665,812,641.95 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 115,279,416 | 115,279,416 | 115,279,416 | 115,279,306 |
| 其他权益工具 | 96,489,947.36 | 96,489,947.36 | 96,489,947.36 | 96,490,723.09 |
| 资本公积 | 410,963,755.31 | 410,706,015.42 | 410,599,708.03 | 412,259,985.75 |
| 减:库存股 | 3,030,264.52 | 1,921,250.12 | 0 | - |
| 其他综合收益 | 0 | - | 0 | - |
| 专项储备 | 0 | - | 0 | - |
| 盈余公积 | 9,953,911.25 | 9,953,911.25 | 9,953,911.25 | 9,861,298.49 |
| 一般风险准备 | 0 | - | 0 | - |
| 未分配利润 | 279,662,169.68 | 291,896,774.85 | 290,814,696.93 | 304,336,230.59 |
| 归属于母公司股东权益合计 | 909,318,935.08 | 922,404,814.76 | 923,137,679.57 | 938,227,543.92 |
| 少数股东权益 | 88,002,456.97 | 89,659,517.17 | 91,504,375.42 | 93,213,009.15 |
| 股东权益合计 | 997,321,392.05 | 1,012,064,331.93 | 1,014,642,054.99 | 1,031,440,553.07 |
| 负债和股东权益合计 | 2,935,174,530.03 | 2,913,552,562.84 | 2,789,880,328.86 | 2,697,253,195.02 |
| 公告日期 | 2025-08-29 | 2025-04-29 | 2025-04-24 | 2024-10-24 |
| 审计意见(境内) | | | 标准无保留意见 | |